Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 7, 2025ACS Applied Materials & Interfaces

A Tumor-Specific Membrane Protein Degradation Platform via Covalent Reaction-Induced Aggregation

View Full Paper
Ask AI
Bookmark
Share

Authors

YXYinsheng XuYZYingjin ZhangBSBenli Song

Discussion

Loading...

Member takes

Overview

Covalent degradation strategy improves anticancer capacity in tumor cells, suggesting new cancer therapy methods.

Key Points

  • MAIN FINDING: CMPATACs enable tumor-specific degradation of membrane proteins without relying on receptors.
  • KEY EVIDENCE: The approach effectively degrades various membrane proteins, including HER2 and EGFR, enhancing anticancer capacity.
  • APPROACH: The method utilizes covalent reactions to aggregate membrane proteins, targeting them for lysosomal degradation.
  • SIGNIFICANCE: This innovation expands the potential for degrading undruggable proteins in cancer therapy, offering new treatment avenues.

Cite This Study

Xu et al. (2025) studied this question.

synapsesocial.com/papers/689dfe90d61984b91e13bdb7https://doi.org/10.1021/acsami.5c09287
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Expanding the Repertoireof Lysosomal Degradationof Membrane Proteins: A Generalizable Strategy Using Multivalent Antibody−PolymerChimeras2026
  2. 2Targeted degradation of cell surface proteins through endocytosis triggered by cell-penetrating peptide-small molecule conjugates2025 · 22 citations
  3. 3Circular Bivalent Aptamer Chimeras Leveraging LDLR-Mediated Lysosomal Shuttling for Targeted Protein Degradation2026
  4. 4Peptide-Mediated Small Molecule Lysosome-Targeting Chimeras for Targeted Degradation of Membrane and Intracellular Proteins2024 · 23 citations
  5. 5Development of Integrin-Facilitated Bispecific Aptamer Chimeras for Membrane Protein Degradation2024 · 47 citations